Drugs / BCG Solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07474519 | Feb 2026 → Dec 2027 expected | non-invasive bladder urothelial carcinoma | Ohio State University Comprehensive Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07474519 ↗ |